⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
TENX News
Tenax Therapeutics, Inc.
Form 8-K
sec.gov
TENX
Form 8-K
sec.gov
TENX
Tenax Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update
globenewswire.com
TENX
Tenax Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
TENX
Tenax Therapeutics Appoints Timothy Healey, MBA as Chief Commercial Officer
globenewswire.com
TENX
Form 8-K
sec.gov
TENX
LNSR
BCRX
MRK
GILD
Tenax Therapeutics Appoints Thomas R. Staab, II as Chief Financial Officer
globenewswire.com
TENX
Improve Recruitment Outcomes Through More Diverse Clinical Trials, Upcoming Webinar Hosted by Xtalks
prnewswire.com
TENX
Form 8-K
sec.gov
TENX
Tenax Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update
globenewswire.com
TENX